Meta-analysis: Antibiotics for Prophylaxis against Hemodialysis Catheter–Related Infections
- 15 April 2008
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 148 (8), 596-605
- https://doi.org/10.7326/0003-4819-148-8-200804150-00004
Abstract
Catheter-related infections cause morbidity and mortality in patients undergoing hemodialysis. To examine whether topical or intraluminal antibiotics reduce catheter-related bloodstream infection compared with no antibiotic therapy in adults undergoing hemodialysis. Electronic databases, trial registries, bibliographies, and conference proceedings up to October 2007, with no language restrictions. Two reviewers independently selected randomized, controlled trials using topical or intraluminal antibiotics for prophylaxis of infection in adults with catheters who are undergoing hemodialysis. Two independent reviewers assessed studies for inclusion, quality, and extracted data. Fixed-effects models were used to estimate pooled rate ratios for outcomes. Topical antibiotics reduced the rate of bacteremia (rate ratio, 0.22 [95% CI, 0.12 to 0.40]; 0.10 vs. 0.45 case of bacteremia per 100 catheter-days), exit-site infection (rate ratio, 0.17 [CI, 0.08 to 0.38]; 0.06 vs. 0.41 case of infection per 100 catheter-days), need for catheter removal, and hospitalization for infection. Intraluminal antibiotics reduced the rate of bacteremia (rate ratio, 0.32 [CI, 0.22 to 0.47]; 0.12 vs. 0.32 case of bacteremia per 100 catheter-days) and need for catheter removal. Intraluminal antibiotics did not significantly reduce the rate of exit-site infection, and no hospitalization data were available for these agents. The evidence base included only 16 trials, and most had less than 6 months of follow-up. Only one third of studies were blinded. Publication bias was evident. Both topical and intraluminal antibiotics reduced the rate of bacteremia as well as the need for catheter removal secondary to complications. Whether these strategies will lead to antimicrobial resistance and loss of efficacy over longer periods remains unclear.Keywords
This publication has 23 references indexed in Scilit:
- Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placementKidney International, 2006
- Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: A randomised, double‐blind clinical trialNephrology, 2006
- Haemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II)Nephrology Dialysis Transplantation, 2005
- Vascular Access and All-Cause MortalityJournal of the American Society of Nephrology, 2004
- Preventing bacterial infections and antimicrobial resistance in dialysis patientsAmerican Journal of Kidney Diseases, 2002
- A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis cathetersNephrology Dialysis Transplantation, 2002
- Vascular access and increased risk of death among hemodialysis patientsKidney International, 2002
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodineKidney International, 1991